May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.2
May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.3
Learning Objectives:
Upon completion of this activity, participants will be able to decide on the best treatment approach for patients with AIH who fail to respond to standard of care
Upon completion of this activity, participants will be able to identify patients with PBC who are likely to progress despite receiving first line therapy with ursodeoxycholic acid
Upon completion of this activity, participants will be able to apply a valid surveillance strategy for hepatobiliary malignancies in patients with PSC
May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.4
Learning Objectives:
Upon completion of this activity, the participant will understand data on liver transplantation of patients with alcohol-associated hepatitis
Upon completion of this activity, the participant will be aware of data on liver transplantation of HCV + organs into HCV - recipients
Upon completion of this activity, the participant will understand strategies to expand the liver donor pool
May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.5
Learning Objectives:
Recognize clinical presentations where high resolution manometry provides diagnostic value
Distinguish major motility disorders that have specific therapeutic options
Identify alternate testing options when high resolution manometry is inconclusive
May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.6
Learning Objectives:
Differentiate between various gastrointestinal motility disorder
Use appropriate drugs for managing these diseases
May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.7
Learning Objective:
Review the recommendations for colon cancer screening in indivduals with a family history of cancer
May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.8
May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.9
Learning Objectives:
Learn the indications for bariatric surgery and endoscopy
Learn the potential advantage of bariatric surgery and endoscopy
Explore the latest endoscopic device available.
May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.95
Learning Objectives:
Describe the epidemiology of duodenoscope-related infections
Summarize the response and request from governing bodies
Discuss methods for enhanced reprocessing and summarize duodenoscope modifications designed to avoid infection transmission
May 1, 2021 12:10pm ‐ May 1, 2021 1:00pm
Identification: 25.96
Learning Objectives:
Identify laboratory testing needed prior to and after initiating a biologic to assess safety and efficacy
Identify when to use proactive and reactive therapeutic drug monitoring for biologics in IBD to improve efficacy and maintain efficacy
Interpret the meaning of biologic drug levels in the setting of proactive and reactive drug monitoring